Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 2/20 | 0.64 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 5/20 | 0.45 |
| ▸ | CCKAR | P32238 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9501463 | 0.80 | LMNA (0.52) | CCKBRSMN1; SMN2 | |
| SCHEMBL9499716 | 0.78 | CCKBR (1.00) | CCKBROPRM1OPRK1CCKAR | |
| SCHEMBL9499432 | 0.75 | OPRM1 (0.49) | CCKBROPRM1OPRK1 | |
| SCHEMBL9500460 | 0.74 | OPRD1 (0.60) | CCKBROPRM1OPRK1CCKAR | |
| SCHEMBL9499330 | 0.72 | CCKBR (0.58) | CCKBROPRM1OPRK1CCKARSMN1; SMN2 | |
| SCHEMBL9501442 | 0.70 | CCKBR (0.62) | CCKBROPRK1CCKARDRD2 | |
| SCHEMBL9682641 | 0.67 | CCKBR (0.37) | CCKBRSMN1; SMN2HTR2A | |
| SCHEMBL9683424 | 0.67 | CCKBR (0.38) | CCKBROPRK1SMN1; SMN2TP53HTR2A | |
| SCHEMBL22495470 | 0.65 | SMN1; SMN2 (0.59) | OPRM1OPRK1SMN1; SMN2TP53RXFP1 | |
| SCHEMBL9501458 | 0.62 | ALDH1A1 (0.36) | CCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0486271-A2 | Cholecystokinin antagonists for treating neurological disorders | MERCK & CO. INC. (US) | 1992-05-20 | — | — | EP | claimed |
| US-4724237-A | GASTROINTESTINAL, CENTRAL NERVOUS, AND APPETITE DISORDERS | MERCK & CO., INC. (US) | 1988-02-09 | — | — | US | claimed |
| EP-0166356-B1 | 2-SUBSTITUTED-AMINOMETHYL-1,4-BENZODIAZEPINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | MERCK & CO. INC. (US) | 1993-09-01 | — | — | EP | disclosed |
| US-5206238-A | Cholecystokinin antagonists | MERCK & CO., INC. (US) | 1993-04-27 | — | — | US | disclosed |
| US-4724237-A | GASTROINTESTINAL, CENTRAL NERVOUS, AND APPETITE DISORDERS | MERCK & CO., INC. (US) | 1988-02-09 | — | — | US | disclosed |
| EP-0166356-A2 | 2-Substituted-aminomethyl-1,4-benzodiazepines, process for their preparation and pharmaceutical compositions containing them | MERCK & CO. INC. (US) | 1986-01-02 | — | — | EP | disclosed |